|
N.V. Toroptsova, O.A. Nikitinskaya
OSTEOPOROSIS IN REAL CLINICAL PRACTICE: FOCUS ON ALFACALCIDOL
|
№19 / 2016
|
|
I.A. Skripnikova
OSTEOPOROSIS - A PEDIATRIC DISEASE WITH GERONTOLOGICAL CONSEQUENCES. WHEN, WHOM AND HOW TO PREVENT IT?
|
№19 / 2016
|
|
A.V. Pashentseva, A.F. Verbovoy
OSTEOPOROSIS IN MEN
|
№16 / 2016
|
|
S.S. Rodionova, U.R. Khakimov
RATIONALE FOR USE OF ALFACALCIDOL IN COMBINATION WITH BISPHOSPHONATES IN POSTMENOPAUSAL AND SENILE FORMS OF SYSTEMIC OSTEOPOROSIS
|
№s3-16 / 2016
|
|
N.Yu. Karpova (1), M.A.Rashid (2), T.V. Kazakova (1), M.E. Yadrov (2)
CALCIUM METABOLISM AND BONE HOMEOSTASIS
|
№s3-16 / 2016
|
|
N.V. Toroptsova (1), I.A. Baranova (2), O.M. Lesnyak (3, 4)
RECOMMENDATIONS FOR USE OF THE RUSSIAN MODEL FRAX® FOR DETERMINING 10-YEAR PROBABILITY OF OSTEOPOROTIC FRACTURES
|
№s3-16 / 2016
|
|
N.Yu. Tretyakova (1, 2)
EFFECT OF SPECIAL TREATMENT ON THE DEVELOPMENT OF OSTEOPOROSIS IN PATIENTS WITH BREAST CANCER IN PREMENOPAUSAL PERIOD
|
№8 / 2016
|
|
E.S. Akarachkova (1), L.R. Kadyrova (2), O.V. Kotova (1)
MAGNESIUM DEFICIENCY AS A CAUSE AND A CONSEQUENCE OF OSTEOPOROSIS
|
№7 / 2016
|
|
D.V. Stafeev, A.Yu. Kochish, S.N. Ivanov
EVALUATION OF THE EFFICACY OF THERAPY OF OSTEOPOROSIS IN PATIENTS WITH EXTRA-ARTICULAR FRACTURES OF THE PROXIMAL FEMUR
|
№5 / 2016
|
|
A.V. Pashentseva, A.F. Verbovoy, O.V. Kosareva, L.A. Sharonova
MODERN POSSIBILITIES OF OSTEOPOROSIS TREATMENT
|
№5 / 2016
|
|
E.V. Biryukova
APPLICATION OF CALCIUM AND VITAMIN D IN CLINICAL PRACTICE - THE KEY TO SUCCESSFUL PREVENTION AND TREATMENT OF OSTEOPOROSIS
|
№20 / 2015
|
|
E.V. Mitroshina, A.F. Verbovoy
OSTEOPOROSIS AND ATHEROSCLEROSIS: WHAT IS THE GENERAL?
|
№19 / 2015
|
Русский
